Press Release Archive

03.02.2009

Pfizer and Bausch & Lomb to Co-Promote Products for the Treatment of Ophthalmic Conditions

03.02.2009

Pfizer Expands Portfolio of Generic Medicines in the U.S. and Europe Through Licensing Agreements with Aurobindo

02.23.2009

Pfizer Discontinues Development of Two Phase 3 Compounds

02.09.2009

Pfizer to Publicly Disclose Payments to U.S. Physicians, Healthcare Professionals and Clinical Investigators

02.04.2009

Pfizer and The Pfizer Foundation Recognize "World Cancer Day" Award $7 Million in Grants to Support Global Cancer Control Efforts

02.03.2009

Pfizer’s Sutent is Recommended as First-Line Treatment for Kidney Cancer Patients by British Health Agency

02.01.2009

Lipitor Significantly Reduced hsCRP Levels in Patients with Stable Coronary Artery Disease, According to New Study

01.30.2009

Pfizer Discontinues Global Phase III Trial of Axitinib for Futility in Advanced Pancreatic Cancer

01.29.2009

Geodon Proven Effective as Adjunctive Maintenance Treatment of Bipolar Disorder

01.27.2009

Pfizer Invites Public to Listen to Audio-Only Webcast of January 27 Investor Luncheon

01.25.2009

MEDIA ADVISORY: Pfizer and Wyeth to Host Live Press Conference in New York

01.25.2009

Pfizer Reports Fourth-Quarter and Full-Year 2008 Results and 2009 Financial Guidance